ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and treatment effects of ATH-1017 in subjects
with Parkinson's Disease Dementia or Dementia with Lewy Bodies, with a randomized treatment
duration of 26 weeks.